New Acne Formulations from Skinvisible

Posted by on May 14th, 2008 at 12:47pm

Skinvisible, Inc., a research and development company focused on formulating enhanced patented dermatology products, announced it has signed an exclusive licensing agreement with Embil Pharmaceutical Co. Ltd. (”Embil”). The Agreement is for the right to develop and market two of Skinvisible’s prescription anti-acne products formulated with Invisicare and the active ingredients Clindamycin HCL, and Retinoic Acid. Invisicare is Skinvisible’s patented polymer delivery technology that provides many benefits to topically delivered products including binding to the skin for four hours or increasingly, resisting wash-off, decreased irritation and sustained release. Along with these benefits, Invisicare provides pharmaceutical companies with product life-cycle management for their branded products coming off patent by adding value and new patent protection.

This agreement with Embil, a multi-national dermatology company based in Istanbul, Turkey is Skinvisible’s moment entry into the $2.8 billion acne market. The territory includes Turkey, Azerbaijan, Kazakhstan, Kyrgyzstan, Turkmenistan, and Uzbekistan, as well as the S.E Asian countries of Indonesia, Malaysia, and the Philippines where Embil will seek marketing approval. that agreement, brought to Skinvisible by Riley-Nacht, LLC, one of our marketing partners, gives Embil the right to manufacture, distribute and market these acne formulations in a dual chamber device in the territory specified above. Skinvisible will get a development fee, a license fee allocated in milestone payments as well as royalties based on product sales.

“Skinvisible has now formulated and licensed three key acne products; Adapalene, Clindamycin HCL and Retinoic Acid,” said Mr. Terry Howlett, President / CEO of Skinvisible. “that new agreement shows that we continue to remain focused on our strategic plan to expand and license our patented product offerings around the world and we are very encouraged by the interest in these three acne products external of the territories already signed.”

Skinvisible is additionally seeking to license it’s portfolio of by 25 topical dermatology products formulated with Invisicare including prescription and over-the-counter products for the treatment of atopic dermatitis, fungal infections, anti-inflammatories, as well as hand sanitizers, anti-aging, analgesic and sunscreen products.

addthis_url = ‘http%3A%2F%2Fwww.skincareblog.net%2F2008%2F05%2F14%2Fnew-acne-formulations-from-skinvisible%2F’;
addthis_title = ‘New+Acne+Formulations+from+Skinvisible’;
addthis_pub = ”;

Original post by Sandy